Cargando…
COVID-19, Influenza and RSV: Surveillance-informed prevention and treatment – Meeting report from an isirv-WHO virtual conference
The International Society for Influenza and other Respiratory Virus Diseases (isirv) and the WHO held a joint virtual conference from 19th-21st October 2021. While there was a major focus on the global response to the SARS-CoV-2 pandemic, including antivirals, vaccines and surveillance strategies, p...
Autores principales: | McKimm-Breschkin, Jennifer L., Hay, Alan J., Cao, Bin, Cox, Rebecca J., Dunning, Jake, Moen, Ann C., Olson, Daniel, Pizzorno, Andrés, Hayden, Frederick G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8684224/ https://www.ncbi.nlm.nih.gov/pubmed/34933044 http://dx.doi.org/10.1016/j.antiviral.2021.105227 |
Ejemplares similares
-
Meeting report: 4th ISIRV antiviral group conference: Novel antiviral therapies for influenza and other respiratory viruses
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2016) -
Prevention and treatment of respiratory viral infections: Presentations on antivirals, traditional therapies and host-directed interventions at the 5th ISIRV Antiviral Group conference
por: McKimm-Breschkin, Jennifer L., et al.
Publicado: (2018) -
Second isirv antiviral group conference: overview
por: Hurt, Aeron C., et al.
Publicado: (2013) -
Overview of the 3rd isirv-Antiviral Group Conference – advances in clinical management
por: Hurt, Aeron C, et al.
Publicado: (2015) -
Management of Influenza Virus Infections with Neuraminidase Inhibitors: Detection, Incidence, and Implications of Drug Resistance
por: McKimm-Breschkin, Jennifer L.
Publicado: (2012)